Medical treatment and comorbidity in polycystic ovary syndrome: an updated review

D Glintborg, M Andersen - Current Opinion in Endocrine and Metabolic …, 2020 - Elsevier
Polycystic ovary syndrome (PCOS) is defined by hyperandrogenism, irregular menses, and
polycystic ovaries when other etiologies are excluded. The risk of type 2 diabetes and …

Polycystic ovary syndrome

A Balen - InnovAiT, 2016 - journals.sagepub.com
Polycystic ovary syndrome is the most common endocrine disturbance to affect women, with
approximately 10–15% of women experiencing this problem. It involves a spectrum of signs …

[HTML][HTML] A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions

RHK Emanuel, J Roberts, PD Docherty… - Frontiers in …, 2022 - frontiersin.org
Polycystic ovary syndrome (PCOS) affects up to 20% of women but remains poorly
understood. It is a heterogeneous condition with many potential comorbidities. This review …

[HTML][HTML] Uric acid level in climacteric women and its association with clinical and metabolic parameters

LA Cota e Souza, GCO D'Angelo, GN da Silva… - Scientific Reports, 2023 - nature.com
Climacteric women often experience unfavorable metabolic changes. Consequently,
identifying markers that may contribute to such undesirable changes is imperative. This …

Polycystic ovary syndrome and the forgotten uterus

P Hosseinzadeh, M Barsky, WE Gibbons, CS Blesson - F&S Reviews, 2021 - Elsevier
Objective To review the features of endometrial and uterine aberrations in women with
Polycystic ovary syndrome (PCOS). Evidence Review PCOS is a common disorder that …

Polycystic ovary syndrome and metabolic disorders: A review of the literature

AT Ali, O Al-Ani, F Al-Ani, F Guidozzi - African Journal of Reproductive …, 2022 - ajol.info
Polycystic ovarian syndrome (PCOS) is one of the most common female endocrinopathies
and is a leading cause of infertility. The syndrome derives its name from the pathological …

[PDF][PDF] An overview on polycystic ovary syndrome (PCOS)

C Muhas, K Nishad, P Naseef… - Technol Innov Pharm …, 2021 - researchgate.net
Polycystic ovary syndrome (PCOS) is one of most common female endocrine disorder that
affects 6-15% of the female population. Women with PCOS have a hormonal imbalance and …

[HTML][HTML] Evaluation and treatment of polycystic ovary syndrome

RS Legro - 2015 - europepmc.org
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among adult
women in the developed world and is characterized by anovulation, androgen excess …

Polycystic Ovary Syndrome (PCOS): Clinical Features, Risk Factors, Biomarkers, Treatment, and Therapeutic Strategies

Q Fatima, H Jeelani, S Abass, M Farooq… - Toxicology and Human …, 2023 - Springer
Among reproductive-age women, the most predominant reproductive-metabolic
endocrinopathy is polycystic ovary syndrome (PCOS). It is of unknown etiology. Women with …

[HTML][HTML] Molecular Research on Polycystic Ovary Syndrome (PCOS)

S Daniele, E Chelucci, G Scarfò, PG Artini - Biomedicines, 2023 - mdpi.com
Polycystic ovary syndrome (PCOS) is an endocrine systemic disorder with a prevalence of
between 5% and 20% that commonly affects childbearing-aged women [1–3]. Principally …